Paget-Schroetter disease surgery: Difference between revisions
Created page with "__NOTOC__ {{ Paget-Schroetter disease }} {{CMG}} ==Overview== ==Surgery== However, J. Ernesto Molina, MD, a vascular surgeon at the University of Minnesota, has expressed t..." |
No edit summary |
||
| Line 6: | Line 6: | ||
==Overview== | ==Overview== | ||
==Surgery== | ==Surgery== | ||
However, J. Ernesto Molina, MD, a vascular surgeon at the University of Minnesota, has expressed the following opinion:<ref>{{cite web|url=http://www.circ.ahajournals.org/cgi/content/full/111/9/e118#R2-160023 |title=Letter Regarding Article by Martinelli et al, "Risk Factors and Recurrence Rate of Primary Deep Vein Thrombosis of the Upper Extremities" * Response -- Molina et al. 111 (9): e118 -- Circulation|accessdate=2007-07-02 |format= |work=}}</ref> | |||
"The current acceptable treatment for that condition is lytic therapy followed by surgery. The patients were followed up to investigate the rate of recurrence. However, if surgery is not done, the problem will invariably recur.2–4 If patients are treated with only anticoagulants and even thrombolytics but no surgery, I expect the recurrence rate to be high." Because "most of the patients who suffer this condition do not have any abnormality in their coagulation mechanism" and in fact suffer from "a direct injury to the endothelium," the "treatment for Paget-Schroetter syndrome ... entails the use of thrombolytics ''followed by surgery'' to decompress the thoracic inlet and widening of the vein, usually with a vein patch." | "The current acceptable treatment for that condition is lytic therapy followed by surgery. The patients were followed up to investigate the rate of recurrence. However, if surgery is not done, the problem will invariably recur.2–4 If patients are treated with only anticoagulants and even thrombolytics but no surgery, I expect the recurrence rate to be high." Because "most of the patients who suffer this condition do not have any abnormality in their coagulation mechanism" and in fact suffer from "a direct injury to the endothelium," the "treatment for Paget-Schroetter syndrome ... entails the use of thrombolytics ''followed by surgery'' to decompress the thoracic inlet and widening of the vein, usually with a vein patch." | ||
Revision as of 17:10, 21 September 2012
|
Paget-Schroetter disease Microchapters |
|
Differentiating Paget-Schroetter disease from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Paget-Schroetter disease surgery On the Web |
|
American Roentgen Ray Society Images of Paget-Schroetter disease surgery |
|
Risk calculators and risk factors for Paget-Schroetter disease surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Surgery
However, J. Ernesto Molina, MD, a vascular surgeon at the University of Minnesota, has expressed the following opinion:[1]
"The current acceptable treatment for that condition is lytic therapy followed by surgery. The patients were followed up to investigate the rate of recurrence. However, if surgery is not done, the problem will invariably recur.2–4 If patients are treated with only anticoagulants and even thrombolytics but no surgery, I expect the recurrence rate to be high." Because "most of the patients who suffer this condition do not have any abnormality in their coagulation mechanism" and in fact suffer from "a direct injury to the endothelium," the "treatment for Paget-Schroetter syndrome ... entails the use of thrombolytics followed by surgery to decompress the thoracic inlet and widening of the vein, usually with a vein patch."